Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial

JAMA

Volumn 293, Issue 4, 2005, Pages 437-446

  Mehta, Shamir R ^a,i   Yusuf, S ⁱ   Díaz, Rafael ^b   Zhu, J ^f,i   Pais, P ^d   Xavier, D ^d,i   Paolasso, E ⁱ   Ahmed, Rashid ^a   Xie, Changchun ^a   Kazmi, Khawar ^e   Tai, Javed ^e   Orlandini, A D ⁱ   Pogue, J ⁱ   Liu, Lisheng ^c   Cronin, L ⁱ   Gupta, R ⁱ   Haridas, K K ⁱ   Jaison, T M ⁱ   Joshi, P P ^i,i   Kerkar, P G ⁱ   Maity, A K ⁱ   Manchanda, S C ⁱ   Naik, S ⁱ   Prabhakaran, D ⁱ   Reddy, S ⁱ   Singh, B ⁱ   Thanikachalam, S ⁱ   Bai, X J ⁱ   Chen, T ⁱ   Cui, J J ⁱ   Cui, T X ⁱ   Fu, S Y ⁱ   Ge, H ⁱ   Li, Q L ⁱ   Li, S M ^i,i   Li, W ^i,i   Li, Y Q ⁱ   Liu, L ^f,i   Liu, Y H ⁱ   Lu, Z R ⁱ   Ma, S P ⁱ   Qiao, D ⁱ   Song, Y C ⁱ   Sun, N L ⁱ   Wang, L H ⁱ   Wang, S W ⁱ   Wang, W ⁱ   Wang, Y ⁱ   Wu, N ⁱ   Wu, Y S ⁱ   Xu, C B ⁱ   Xu, S C ⁱ   Xu, Z M ⁱ   Yang, G J ⁱ   Yang, H S ⁱ   Zhang, C Z ⁱ   Zhang, S T ⁱ   Zhang, W J ⁱ   Zhou, J C ⁱ   Almahmeed, W ⁱ   Avezum, A ⁱ   Castro, P ⁱ   Corbalan R ⁱ   Pitarch Flors, R ⁱ   Lombana, B M ⁱ   Marano, L ⁱ   Mcguire, D ⁱ   Isea Perez, J E ⁱ   Soares Piegas, L ⁱ   Van De Werf, F ⁱ   White, H ⁱ   Zubaid, M ⁱ   Faruqi, A M ⁱ   Rasool, I ⁱ   Soomro, K ⁱ   ul Banna, H ⁱ   Ahmed, R J ⁱ   Pavlov, S ⁱ   Zhao, F ⁱ   Tsuluca, I ⁱ   Molec, M ⁱ   Holadyk Gris, I ⁱ   Ahmed, K ⁱ   Freeda, D ^d   Lidwin, S ^d   Chenniappan, M ⁱ   Isaac, B ⁱ   Iyengar, S S ⁱ   Joshi, P ⁱ   Kalantri, S P ⁱ   Kaushik, S K ⁱ   Mahorkar, U K ⁱ   Narendra, J ⁱ   Paul, S K ⁱ   Santhosh, M J ⁱ   Sastry, B K S ⁱ   Siwach, S B ⁱ   Varghese, K ⁱ   Yang, H ^f   Yang, Y ^f   Zhang, X ^f   Tan, H ^f   Tang, J ^f   Li, X ^f   Yan, L ^f   Zhang, Y ^f,i,i,i   Li, J ^f,i   Bai, M Y ⁱ   Jiang, Y Q ⁱ   Lang, S Y ⁱ   Shi, X Y ⁱ   Tian, Z R ⁱ   Wang, K ⁱ   Yan, D H ⁱ   Yu, S Y ⁱ   Pascual, A ^g   Ozcoidi, H ^g   Cuesta, C ^g   Wojdyla, D ^g   Font, G M ^g   Genisans, M I ^g   Chandna, I ^h,i   Rafiq, M ^h,i   Dadani, N ^h   Fatima, S S ^h   Rehman, S ^h   Adil, S ⁱ   Bhojomal, K ⁱ   Hameed, A ⁱ   Khan, S A ⁱ   Sleight, P ⁱ   Baigent, C ⁱ   Hirsh, J ⁱ   Taylor, W ⁱ   Tognoni, G ⁱ   Bacher, P ⁱ   Bender, N ⁱ   Legler, U ⁱ   Magin, U ⁱ   Raschke, U ⁱ   San Mauro, M ⁱ   Brito, M A ⁱ   Alves De Lima, A ⁱ   Ahuad Guerrero, R A ⁱ   Nordaby, R ⁱ   Barcudi, R J ⁱ   Bono, J ⁱ   Ledesma, R E ⁱ   Ramos, H R ⁱ   Caccavo, A ⁱ   Macin, S M ⁱ   Ferreyra Cantante, S N ⁱ   Caime, G D ⁱ   Cartasegna, L R ⁱ   Perrino, O A ⁱ   Gambarte, A J ⁱ   Marzetti, E ⁱ   Garrido, M ⁱ   Balado, R J ⁱ   Martinez, C B ⁱ   Fernandez, A A ⁱ   Ferro Queirel, E ⁱ   Balbi, J O ⁱ   Amuchastegui, G ⁱ   Covelli, G ⁱ   Gentile, A ⁱ   Girino, C E ⁱ   Lopez J ⁱ   Monti, R ⁱ   Pellizon, O ⁱ   Ramos, J L ⁱ   Zapata, G ⁱ   Cuneo, C A ⁱ   Sanchez, J A ⁱ   Albisu, J P ⁱ   Berli, M A ⁱ   Hominal, M A ⁱ   Peleteiro Marino R A ⁱ   Mezzina, V ⁱ   Avila, E M ⁱ   Baselga, P ⁱ   Castellanos, C R ⁱ   Luciardi, H L ⁱ   Lobo Marquez, L L ⁱ   Muntaner, J ⁱ   Good God, E M ⁱ   Reis, G ⁱ   Mello Soares, D M ⁱ   Bodanese, L C ⁱ   Manenti, E ⁱ   Prestes, L ⁱ   De Castro Amino, J G ⁱ   Uchoa Azevedo, R ⁱ   Carvalho, A C C ⁱ   Ramos, R F ⁱ   Alcaino, M ⁱ   Castro Galvez, P ⁱ   Corbalan Herreros R ⁱ   Liu, H ^i,i   Wang, R ⁱ   Liu, Z C ⁱ   Tian, X ⁱ   Wang, G ^i,i   Nan, Z ⁱ   Zhang, J ⁱ   Zai, C ⁱ   Chen, W ⁱ   Gao, M ⁱ   Hu, D ⁱ   Jia, S ⁱ   Li, D X ⁱ   Li, Q ^i,i   Liu, S L ⁱ   Sun, Y ⁱ   Wang, B ⁱ   Xie, G F ⁱ   Xu, Z ^i,i   Yang, X ⁱ   Zhao, M ⁱ   Zhao, X ⁱ   Fang, Z ⁱ   Liu, S Y ⁱ   Ma, Z ⁱ   Jiang, Y ⁱ   Zhen, Z ⁱ   Huo, F ⁱ   Yang, H G ⁱ   Miao, Y ⁱ   Yang, C M ⁱ   Chi, X ⁱ   Liu, Z X ⁱ   Zhou, S ⁱ   Zhou, F S ⁱ   Guo, R ⁱ   Jing, K ⁱ   Ren, S ⁱ   Zhao, J ⁱ   Bai, H ⁱ   Cheng, C ⁱ   Cheng, J ⁱ   Hao, X ⁱ   Li, H ^i,i   Li, W G ⁱ   Wang, S ^i,i   Zhang, W ⁱ   Li, L ⁱ   Fu, S ⁱ   Shao, J ⁱ   Tan, X ⁱ   Chen, S ⁱ   Fu, J ⁱ   Zheng, Q ⁱ   Ma, J ⁱ   Chen, H ⁱ   Ma, H ⁱ   Gong, L ⁱ   Zhang, Z ^i,i   Li, F ⁱ   Yang, B ⁱ   Zhou, L S ⁱ   Wang, Z ^i,i   Sun, X ⁱ   Tao, G ⁱ   Wang, Q ⁱ   Guo, X ⁱ   Wang, X ⁱ   Zai, K ⁱ   Cui, Q ⁱ   Fan, S ⁱ   Liu, W ⁱ   Meng, Q ⁱ   Qi, G ⁱ   Qin, Y ⁱ   Wang, N ⁱ   Xu, G ⁱ   Yin, X ⁱ   Zhang, Q ⁱ   Zhang, S ⁱ   Liu, R ⁱ   Wang, F ⁱ   Li, W K ⁱ   Zhang, H ⁱ   Xu, X ⁱ   Ma, R ⁱ   Guan, F ⁱ   Yang, T ⁱ   Zhqo, R ⁱ   Huang, J ⁱ   Li, A ⁱ   Zhou, J ⁱ   You, X ⁱ   Hao, L ⁱ   Zhangfang, F ⁱ   Ma, X ⁱ   Shen, C ⁱ   Hou, Z ⁱ   Zho, N F ⁱ   Huang, G ⁱ   Guo, P ⁱ   Lou, J ⁱ   Wang, Q P ⁱ   Jiang, X ⁱ   Li, Z ⁱ   Tian, D ⁱ   Wu, Z D ⁱ   Yang, M G ⁱ   Li, Z C ⁱ   Yang, S G ⁱ   Tu, Y ⁱ   He, C ⁱ   Cao, Y ⁱ   Han, Y ⁱ   Yang, J H ⁱ   Dong, S ⁱ   Li, D F ⁱ   Zhang, Q F ⁱ   Fan, Z ⁱ   An, D Q ⁱ   Liu, J ⁱ   Yang, G ⁱ   Xu, X C ⁱ   Xia, Y ⁱ   Xu, H ⁱ   Wang, T ⁱ   Li, D ⁱ   Wei, J ⁱ   Yang, P ⁱ   Liu, C Y ⁱ   Shang, S ⁱ   Zhang, Y G ⁱ   Hernandez Leyva, E ⁱ   Cano Lopez, N ⁱ   Gonzalez Medina, A R ⁱ   Kanakakis, J E ⁱ   Nanas, J N ⁱ   Papazoglou, P D ⁱ   Srinivas, J ⁱ   Srinivasulu, B ⁱ   Dani, S ⁱ   Prajapati, J ⁱ   Deepak, G ⁱ   Shallam, J F ⁱ   Nesaraj, K J ⁱ   Kumar, A ⁱ   Sharma, R K ⁱ   Balasubramaniyan, S ⁱ   Chidambaram, N ⁱ   Umrani, R ⁱ   Chandra, S ⁱ   Dwivedi, S ⁱ   Kishore, R ⁱ   Kumar, B J ⁱ   Kumble, Y ⁱ   Mehrotra, S ⁱ   Nayak, P R ⁱ   Ramesh, S S ⁱ   Shetty, P K ⁱ   Trivedi, S K ⁱ   Beniwal, R ⁱ   Kalla, A ⁱ   Panwar, R B ⁱ   Alexander, K G ⁱ   Bindu, A V ⁱ   Nambiar, A ⁱ   Barkavi, D ⁱ   Kalanidhi, A ⁱ   Pradeep, T ⁱ   Rajesh, J ⁱ   Ramesh, M ⁱ   Shanmugasundaram, S ⁱ   Kumar, P ⁱ   Sidhu, G ⁱ   Singh, R ⁱ   Pradeep, K N ⁱ   Mittal, A ⁱ   Bijapure, J B ⁱ   Rao, M S ⁱ   Mohanarjun, N G ⁱ   Rao, M B ⁱ   Babu, B R ⁱ   Dinesh, N ⁱ   Jain, R K ⁱ   Jiwani, P A ⁱ   Padmanabhan, T N C ⁱ   Raju, B S ⁱ   Rajaram, R ⁱ   Rao, A S V N ⁱ   Rao, D ⁱ   Rao, V S P ⁱ   Sinha, S ⁱ   Bharani, A ⁱ   Verma, G ⁱ   Tongia, R K ⁱ   Kalra, S ⁱ   Sharma, S ⁱ   Mehrotra, R ⁱ   Sanghvi, S ⁱ   Soni, O P ⁱ   Biswas, A D ⁱ   Boben, J ⁱ   Jacob, G ⁱ   Joseph, J ⁱ   Puri, A ⁱ   Puri, V K ⁱ   Singh, H ⁱ   Calton, R ⁱ   Aneja, G K ⁱ   Nyayadhish, P ⁱ   Nathani, P J ⁱ   Rane, S K ⁱ   Fulwani, M ⁱ   Jain, A S ⁱ   Salkar, R G ⁱ   Somani, A ⁱ   Wadhwani, R ⁱ   Zawar, S D ⁱ   Shegokar, V E ⁱ   Tungikar, S L ⁱ   Vijan, V ⁱ   Trehan, R ⁱ   Garg, A ⁱ   Verma, S ⁱ   Borade, S ⁱ   Duggal, D ⁱ   Hiremath, J ⁱ   Jagdish, ⁱ   Katyal, V K ⁱ   Devendrappa, H R ⁱ   Ratnakar, ⁱ   Latha, P B ⁱ   Manoj, E B ⁱ   Mohanan, P P ⁱ   Gandhimadhinathan, P ⁱ   Jeremaiah, K ⁱ   Raj, B S V ⁱ   Udaysankar, R ⁱ   Chhaparwal, J K ⁱ   Chandy, S T ⁱ   Gupta, S N ⁱ   Raghavan, S ⁱ   Ramesh, P ⁱ   Reddy, V S ⁱ   Srinivas, P ⁱ   Rao, K D ⁱ   Malipeddi, B R ⁱ   Murthy, G S R ⁱ   Joshi, R ⁱ   Patil, S ⁱ   Tredici, S ⁱ   Agnelli, D ⁱ   Assanelli, E ⁱ   Bozzano, A ⁱ   Marsano, L ⁱ   Crivello, R ⁱ   Nejrotti, A ⁱ   Abdulminem, A ⁱ   Saad, H ⁱ   Martinez Sanchez, J ⁱ   Carrillo Calvillo, J ⁱ   Hamer, A ⁱ   Banna, H U ⁱ   Lopez Ferre, J ⁱ   Freedman, R J ⁱ   Transk III, N ⁱ   Almeida, D ⁱ   Lujan, P J C ⁱ   Mata, C ⁱ   Becerra, C ⁱ   Gonzalez, K ⁱ   Torres, F ⁱ   Alvarez, M A ⁱ   Carrillo, E ⁱ   more..

^a MCMASTER UNIVERSITY   (Canada)

^b Estudios Cardiologica Latin America   (Argentina)

^c FUWAI HOSPITAL   (China)

^d ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^e AGA KHAN UNIVERSITY   (Pakistan)

^f Beijing Hypertensive League Institute   (China)

^g ELCA   (Argentina)

^h AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

ⁱ Aga Khan University Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; GLYCERYL TRINITRATE; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; POTASSIUM; REVIPARIN; STREPTOKINASE; TICLOPIDINE; UROKINASE;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

EID: 12544259347     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.4.437     Document Type: Article

References (27)

1. Sodi-Pallares D, Testelli MR, Fishleder BL, et al. Effects of an intravenous infusion of potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction: a preliminary clinical report. Am J Cardiol. 1962;9:166-181.
2. Apstein CS, Tacgtmeyer H. Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial. Circulation. 1997; 96:1074-1077.
3. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischemia and arrhythmias. Lancet. 1994;343:155-158.
4. Opie LH, Tansey M, Kennelly BM. Proposed metabolic vicious circle in patients with large myocardial infarction and high plasma free fatty acid concentrations. Lancet. 1977;2:890-892.
5. Oliver MF, Kurien VA, Greenwood TW. Relation between serum free fatty acids and arrhythmias and death after acute myocardial infarction. Lancet. 1968; 1:710-714.
6. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation. 2000;101:2090-2094.
7. 2- receptor stimulation by circulating epinephrine. N Engl J Med. 1983;309:1414-1419.
8. Obeid AI, Varrier RL, Lown B. Influence of glucose, insulin, and potassium on vulnerability to ventricular fibrillation in the canine heart. Circ Res. 1978; 43:601-608.
9. Yusuf S, Mehta SR, Díaz R, et al. Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction. Am Heart J. 2004;148: 1068-1078.
10. CREATE Trial Group Investigators. Effects of reviparin, a low-molecular-weight-heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA. 2005;293:427-436.
11. Díaz R, Paolasso EA, Piegas LS, et al; ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Metabolic modulation of acute myocardial infarction. Circulation. 1998;98:2227-2234.
12. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
13. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomized controlled trials. Lancet. 1998;351:47-52.
14. Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ. 1991;303:1499-1503.
15. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
16. Magnesium in Coronaries (MAGIC) Trial Investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet. 2002;360:1189-1196.
17. Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988;1:1088-1092.
18. Eikelboom JW, Mehta SR, Pogue J, Yusuf S. Safety outcomes in meta-analyses of phase 2 vs phase 3 randomized trials: intracranial hemorrhage in trials of bolus thrombolytic therapy. JAMA. 2001;285:444-450.
19. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93-98.
20. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucose-insulin- potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999;13: 191-200.
21. van der Horst IC, Zijlstra F, van't Hof AW, et al; Zwolle Infarct Study Group. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the Glucose-Insulin-Potassium Study: a randomised trial. J Am Coll Cardiol. 2003;42:784-791.
22. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
23. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
24. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40:1748-1754.
25. Nordrehaug JE, Johannessen KA, von der Lippe LG. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation. 1985;71:645-649.
26. Hulting J. In-hospital ventricular fibrillation and its relation to serum potassium. Acta Med Scand Suppl. 1981;647:109-116.
27. Solomon RJ, Cole AG. Importance of potassium in patients with acute myocardial infarction. Acta Med Scand Suppl. 1981;647:87-93.